Cargando…

Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles

BACKGROUND: Circulating tumor cells (CTCs) carry a wealth of information on primary and metastatic tumors critical for enhancing the understanding of the occurrence, progression and metastasis of non-small cell lung cancer (NSCLC). However, the low sensitivity of traditional tumor detection methods...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Naixin, Liu, Lei, Li, Ping, Xu, Yuan, Hou, Yingshuo, Peng, Jiaxi, Song, Yang, Bing, Zhongxing, Wang, Yadong, Wang, Yanyu, Jia, Ziqi, Yang, Xiaoying, Li, Da, Xu, Huihui, Yu, Qian, Li, Shanqing, Hu, Zhiyuan, Yang, Yanlian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475553/ https://www.ncbi.nlm.nih.gov/pubmed/32944338 http://dx.doi.org/10.21037/jtd-20-1026A

Ejemplares similares

Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer
por: Yang, Huaxia, et al.
Publicado: (2021)

Pathological complete response to neoadjuvant ceritinib of a crizotinib‐resistant, stage IIIB non‐small cell lung cancer with ALK rearrangement: A case report
por: Bing, Zhongxing, et al.
Publicado: (2021)

Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer
por: Li, Wenzhe, et al.
Publicado: (2022)

Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
por: Song, Yang, et al.
Publicado: (2023)

Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q
por: Song, Yang, et al.
Publicado: (2020)

First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
por: Jia, Ziqi, et al.
Publicado: (2020)

DNA methylation patterns at and beyond the histological margin of early-stage invasive lung adenocarcinoma radiologically manifested as pure ground-glass opacity
por: Jia, Ziqi, et al.
Publicado: (2021)

Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients
por: Cao, Lei, et al.
Publicado: (2022)

Expression and prognostic analyses of ITGA11, ITGB4 and ITGB8 in human non-small cell lung cancer
por: Wu, Pancheng, et al.
Publicado: (2019)

Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution
por: Li, Kaidi, et al.
Publicado: (2017)

Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer
por: Liang, Naixin, et al.
Publicado: (2022)

Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer
por: Wang, Yadong, et al.
Publicado: (2022)

Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report
por: Wang, Yadong, et al.
Publicado: (2021)

Impact of changing treatment strategy based on circulating tumor cells on postoperative survival of breast cancer
por: Wang, Zihan, et al.
Publicado: (2022)

Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy
por: Yue, Chunyan, et al.
Publicado: (2018)

Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus
por: Yang, Huaxia, et al.
Publicado: (2017)

Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study
por: Yang, Huaxia, et al.
Publicado: (2020)

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma
por: Wu, Pancheng, et al.
Publicado: (2020)

Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both in vitro and in vivo
por: Li, Kaidi, et al.
Publicado: (2017)

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis
por: Xue, Jianchao, et al.
Publicado: (2022)

Prognostic Relevance of Estrogen Receptor Status in Circulating Tumor Cells in Breast Cancer Patients Treated With Endocrine Therapy
por: Zhou, Ying, et al.
Publicado: (2022)

Mature Red Blood Cells Contain Long DNA Fragments and Could Acquire DNA from Lung Cancer Tissue
por: Liang, Naixin, et al.
Publicado: (2023)

Comprehensive genomic profiling aids in understanding the lesion origins of a patient with six synchronous invasive lung adenocarcinomas: a case study
por: Song, Yang, et al.
Publicado: (2020)

KLF8 overexpression promotes the growth of human lung cancer cells by promoting the expression of JMJD2A
por: Ma, Dongjie, et al.
Publicado: (2019)

HER2 status of CTCs by peptide-functionalized nanoparticles as the diagnostic biomarker of breast cancer and predicting the efficacy of anti-HER2 treatment
por: Wang, Mengting, et al.
Publicado: (2022)

A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activity in vitro and in vivo
por: Li, Xiaojin, et al.
Publicado: (2014)

肺微小脑膜上皮样结节——认知进展与争论
por: LI, Haochen, et al.
Publicado: (2023)

HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinoma
por: Jia, Ziqi, et al.
Publicado: (2021)

Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications
por: Liu, Mingpeng, et al.
Publicado: (2021)

Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5
por: Fang, Xiaocui, et al.
Publicado: (2017)

An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer
por: Zhou, Jinmei, et al.
Publicado: (2022)

The causal relationship between circulating cytokines and critically ill COVID-19: A bidirectional Mendelian randomization analysis
por: Yang, Yu, et al.
Publicado: (2022)

Targeting the CXCR4/CXCL12 axis with the peptide antagonist E5 to inhibit breast tumor progression
por: Guo, Hua, et al.
Publicado: (2017)

Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis
por: Li, Xiaojin, et al.
Publicado: (2015)

Assay design for unambiguous identification and quantification of circulating pathogen-derived peptide biomarkers
por: Shu, Qingbo, et al.
Publicado: (2022)

Recent advances in peptide-based nanomaterials for targeting hypoxia
por: Wang, Jun, et al.
Publicado: (2021)

An Externally-Validated Dynamic Nomogram Based on Clinicopathological Characteristics for Evaluating the Risk of Lymph Node Metastasis in Small-Size Non-small Cell Lung Cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Single-molecule insights into surface-mediated homochirality in hierarchical peptide assembly
por: Chen, Yumin, et al.
Publicado: (2018)

Quantification of Rare Circulating Tumor Cells in Non-Small Cell Lung Cancer by Ligand-Targeted PCR
por: Lou, Jiatao, et al.
Publicado: (2013)

Global secretome characterization of A549 human alveolar epithelial carcinoma cells during Mycoplasma pneumoniae infection
por: Li, Shuxian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jabe03emg8n2n5p261km1tevdq